In light of the striking effects of GPx2 on the malignant phenotype, we sought to examine the effect of GPx2 loss on tumor heterogeneity at the single-cell level to identify potential cell populations (i.e., clusters) that might drive BC progression. Here, GPX2 is linked to breast cancer.